{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:54:11Z","timestamp":1789757651045,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jns.2022.120317","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:27:12Z","timestamp":1654687632000},"page":"120317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clinical implication of denervation in sporadic inclusion body myositis"],"prefix":"10.1016","volume":"439","author":[{"given":"Seiya","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kazuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyo","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120317_bb0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0010","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2009.173823","article-title":"Inclusion body myositis: old and new concepts","volume":"80","author":"Amato","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120317_bb0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-011-6185-8","article-title":"Increase in number of sporadic inclusion body myositis (sIBM) in Japan","volume":"259","author":"Suzuki","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2169\/internalmedicine.52.8910","article-title":"Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience","volume":"52","author":"Nakanishi","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2022.120317_bb0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/NEN.0b013e31826183c8","article-title":"Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis","volume":"71","author":"Askanas","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2 Suppl 1","key":"10.1016\/j.jns.2022.120317_bb0030","first-page":"S20","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC International Workshop: inclusion body Myositis, 2-4 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2022.120317_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2022.120317_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol."},{"issue":"2 Suppl 1","key":"10.1016\/j.jns.2022.120317_bb0055","first-page":"S39","article-title":"Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition","volume":"66","author":"Askanas","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0060","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.neurobiolaging.2013.12.029","article-title":"Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy","volume":"35","author":"Cortese","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2022.120317_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00186623","article-title":"Inclusion body myositis: clinical and histopathological features of 36 patients","volume":"71","author":"Beyenburg","year":"1993","journal-title":"Clin. Investig."},{"key":"10.1016\/j.jns.2022.120317_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.63.6.776","article-title":"The role of quantitative electromyography in inclusion body myositis","volume":"63","author":"Brannagan","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120317_bb0075","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.58.8.1253","article-title":"Inclusion body myositis mimicking motor neuron disease","volume":"58","author":"Dabby","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mus.23292","article-title":"Electromyographs of the flexor digitorum profundus muscle are useful for the diagnosis of inclusion body myositis","volume":"46","author":"Hokkoku","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2022.120317_bb0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00002281-199511000-00005","article-title":"New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies","volume":"7","author":"Askanas","year":"1995","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2022.120317_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/WNL.48.1.29","article-title":"Inclusion body myositis: no evidence for a neurogenic component","volume":"48","author":"Luciano","year":"1997","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1152\/physrev.1995.75.2.339","article-title":"Acetylcholine receptor gene expression at the developing neuromuscular junction","volume":"75","author":"Duclert","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jns.2022.120317_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01674266","article-title":"Control of acetylcholine receptors in skeletal muscle","volume":"8","author":"Witzemann","year":"1989","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.jns.2022.120317_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","article-title":"Agrin acts via a MuSK receptor complex","volume":"85","author":"Glass","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.jns.2022.120317_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0896-6273(02)00783-3","article-title":"Regulation of AChR clustering by Dishevelled interacting with MuSK and PAK1","volume":"35","author":"Luo","year":"2002","journal-title":"Neuron."},{"key":"10.1016\/j.jns.2022.120317_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-016-0101-y","article-title":"Failed reinnervation in aging skeletal muscle","volume":"6","author":"Aare","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.jns.2022.120317_bb0120","series-title":"Amyotrophic Lateral Scler Other Motor Neuron Disord","first-page":"293","article-title":"World Federation of Neurology Research Group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000"},{"key":"10.1016\/j.jns.2022.120317_bb0125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-015-7680-0","article-title":"Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy","volume":"262","author":"Maeshima","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/mus.25405","article-title":"Transforming growth factor-\u03b2 signaling is upregulated in sporadic inclusion body myositis","volume":"55","author":"Noda","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2022.120317_bb0135","first-page":"166","article-title":"MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies","volume":"1","author":"Bartoccioni","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jns.2022.120317_bb0140","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000549","article-title":"Myalgia with the presence of pathologic EMG correlates with perimysial inflammatory infiltrates","volume":"6","author":"Johannssen","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2022.120317_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mus.22291","article-title":"Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials","volume":"45","author":"Hama","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2022.120317_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pmr.2012.08.017","article-title":"Electrodiagnostic evaluation of myopathies","volume":"24","author":"Paganoni","year":"2013","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.jns.2022.120317_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151376","article-title":"Distinct muscle biopsy findings in genetically defined adult-onset motor neuron disorders","volume":"11","author":"Jokela","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2022.120317_bb0160","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","article-title":"Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis","volume":"266","author":"Ito","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120317_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm5029","article-title":"Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology","volume":"8","author":"Tsujikawa","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jns.2022.120317_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0896-6273(88)90081-5","article-title":"Acetylcholine receptor alpha-, beta-, gamma-, and delta-subunit mRNA levels are regulated by muscle activity","volume":"1","author":"Goldman","year":"1988","journal-title":"Neuron."},{"key":"10.1016\/j.jns.2022.120317_bb0175","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.clinph.2007.03.023","article-title":"Single-fiber electromyography in sporadic inclusion body myopathy","volume":"118","author":"Hatanaka","year":"2007","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2022.120317_bb0180","series-title":"Diagnostic Accuracy of Muscle Biopsy and Electromyography in 123 Patients with Neuromuscular Disorders, In vivo","first-page":"1647","volume":"32","author":"Constantinides","year":"2018"},{"key":"10.1016\/j.jns.2022.120317_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11926-013-0329-z","article-title":"Update on treatment of inclusion body myositis","volume":"15","author":"Breithaupt","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2022.120317_bb0190","first-page":"S30","article-title":"The current status of treatment for inclusion-body myositis","volume":"66","author":"Griggs","year":"2006","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/WNL.58.2.326","article-title":"Intravenous immunoglobulin for dysphagia of inclusion body myositis","volume":"58","author":"Cherin","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2022.120317_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00005792-199307000-00002","article-title":"The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy","volume":"72","author":"Leff","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jns.2022.120317_bb0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13023-016-0524-x","article-title":"Multicenter questionnaire survey for sporadic inclusion body myositis in Japan","volume":"11","author":"Suzuki","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2022.120317_bb0215","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.jns.2022.120317_bb0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.10121","article-title":"Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo","volume":"51","author":"Badrising","year":"2002","journal-title":"Ann. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:31Z","timestamp":1758384031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"alternative-id":["S0022510X22001794"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120317","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implication of denervation in sporadic inclusion body myositis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120317"}}